{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:10:55Z","timestamp":1790122255441,"version":"4.0.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,22]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Ankylosing spondylitis (AS), the most common form of spondyloarthropathy, is a chronic, progressive multi-system inflammatory disorder characteristically affecting the sacroiliac joints and axial skeleton. Although the exact mechanisms underlying the pathogenesis of AS remain to be elucidated, the presence of human leucocyte antigen (HLA)-B27 is known to markedly increase its risk of development. Current treatments include non-steroidal anti-inflammatory drugs (NSAIDs) and tumour necrosis factor (TNF) blockers. In recent years, the interleukin (IL)-23\/IL-17 pathway has been shown to have significance in the pathogenesis of AS and treatment modalities targeting this pathway have been shown to be beneficial in various other inflammatory conditions. This review provides an overview of the IL-23\/IL-17 pathway in the pathogenesis of AS and summarizes new potential treatments for AS and related inflammatory diseases.<\/jats:p>","DOI":"10.1111\/cei.12670","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T03:50:52Z","timestamp":1434513052000},"page":"30-36","source":"Crossref","is-referenced-by-count":94,"title":["The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment"],"prefix":"10.1093","volume":"183","author":[{"given":"H","family":"Jethwa","sequence":"first","affiliation":[{"name":"Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bowness","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Trust, Oxford, UK"},{"name":"Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science, Oxford OX3 7LD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"2021111804090391100_cei12670-bib-0001","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLOS Med"},{"key":"2021111804090391100_cei12670-bib-0002","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA and the environment","volume":"40","author":"Brown","year":"2007","journal-title":"Arthritis Rheumatol"},{"key":"2021111804090391100_cei12670-bib-0003","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"key":"2021111804090391100_cei12670-bib-0004","doi-asserted-by":"crossref","first-page":"214.","DOI":"10.1186\/ar4228","article-title":"Microbiomes, the gut and ankylosing spondylitis","volume":"15","author":"Costello","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2021111804090391100_cei12670-bib-0005","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"2021111804090391100_cei12670-bib-0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021111804090391100_cei12670-bib-0007","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"2021111804090391100_cei12670-bib-0008","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"2021111804090391100_cei12670-bib-0009","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.38647","article-title":"T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity","volume":"66","author":"Piper","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021111804090391100_cei12670-bib-0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"2021111804090391100_cei12670-bib-0011","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"2021111804090391100_cei12670-bib-0012","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR\u03b3t+ CD3+ CD4\u2013CD8\u2013 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2021111804090391100_cei12670-bib-0013","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20061099","article-title":"Interleukin-23 drives innate and T cell-mediated intestinal inflammation","volume":"203","author":"Hue","year":"2006","journal-title":"J Exp Med"},{"key":"2021111804090391100_cei12670-bib-0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3410\/B2-40","article-title":"The role of IL-23 in the immunopathogenesis of psoriasis","volume":"2","author":"Di Meglio","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"2021111804090391100_cei12670-bib-0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"2021111804090391100_cei12670-bib-0016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"2021111804090391100_cei12670-bib-0017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"2021111804090391100_cei12670-bib-0018","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human Th17 cells produce IFN-\u03b3 or IL-10 are regulated by IL-1\u03b2","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"2021111804090391100_cei12670-bib-0019","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"2021111804090391100_cei12670-bib-0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"2021111804090391100_cei12670-bib-0021","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J Clin Invest"},{"key":"2021111804090391100_cei12670-bib-0022","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/jid.2008.85","article-title":"T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis","volume":"128","author":"Blauvelt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2021111804090391100_cei12670-bib-0023","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"2021111804090391100_cei12670-bib-0024","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.170.11.5438","article-title":"IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14\/p40 transgenic mice: evidence for enhanced cutaneous immunity","volume":"170","author":"Kopp","year":"2003","journal-title":"J Immunol"},{"key":"2021111804090391100_cei12670-bib-0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2021111804090391100_cei12670-bib-0026","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"key":"2021111804090391100_cei12670-bib-0027","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"2021111804090391100_cei12670-bib-0028","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Cutting edge: mast cells express IL-17A in rheumatoid arthritis synovium","volume":"184","author":"Hueber","year":"2010","journal-title":"J Immunol"},{"key":"2021111804090391100_cei12670-bib-0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2001","journal-title":"Arthritis Rheumatol"},{"key":"2021111804090391100_cei12670-bib-0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"2021111804090391100_cei12670-bib-0031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/ard.2010.133322","article-title":"Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese","volume":"70","author":"Davidson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021111804090391100_cei12670-bib-0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.55.4.268","article-title":"HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom","volume":"55","author":"Brown","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"2021111804090391100_cei12670-bib-0033","volume-title":"Overview of Ankylosing Spondylitis Genetics and Pathogenesis","author":"Bowness"},{"key":"2021111804090391100_cei12670-bib-0034","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.59.11.883","article-title":"Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis","volume":"59","author":"Brown","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2021111804090391100_cei12670-bib-0035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/ard.2005.046847","article-title":"Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese","volume":"65","author":"Chou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021111804090391100_cei12670-bib-0036","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"2021111804090391100_cei12670-bib-0037","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/art.24933","article-title":"Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population","volume":"60","author":"Davidson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021111804090391100_cei12670-bib-0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/kes254","article-title":"Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis","volume":"52","author":"Jadon","year":"2013","journal-title":"Rheumatology"},{"key":"2021111804090391100_cei12670-bib-0039","doi-asserted-by":"crossref","first-page":"e17160","DOI":"10.1371\/journal.pone.0017160","article-title":"The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans","volume":"6","author":"Di Meglio","year":"2011","journal-title":"PLOS ONE"},{"key":"2021111804090391100_cei12670-bib-0040","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondyloarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021111804090391100_cei12670-bib-0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021111804090391100_cei12670-bib-0042","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment IL-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021111804090391100_cei12670-bib-0043","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/art.34538","article-title":"Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis","volume":"64","author":"Payeli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021111804090391100_cei12670-bib-0044","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"2021111804090391100_cei12670-bib-0045","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"2021111804090391100_cei12670-bib-0046","article-title":"Secukinumab, a monoclonal antibody to interleukin-17A, significantly improves signs and symptoms of active ankylosing spondylitis: results of a 52-week phase 3 randomized placebo-controlled trial with intravenous loading and subcutaneous maintenance dosing","volume":"66","author":"Baeten","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 1","key":"2021111804090391100_cei12670-bib-0047","article-title":"Secukinumab, a monoclonal antibody to interleukin-17A, significantly improves physical function and quality of life in subjects with active ankylosing spondylitis: results of a phase 3 randomized, placebo-controlled trial with intravenous loading and subcutaneous maintenance dosing","volume":"66","author":"Deodhar","year":"2014","journal-title":"Arthritis Rheum"},{"key":"2021111804090391100_cei12670-bib-0048","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021111804090391100_cei12670-bib-0049","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3 directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12670","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/1\/30\/41125970\/cei12670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/1\/30\/41125970\/cei12670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:26:43Z","timestamp":1641036403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/183\/1\/30\/6412191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,30]]},"published-print":{"date-parts":[[2015,12,22]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12670","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,1]]},"published":{"date-parts":[[2015,9,30]]}}}